Trulieve Cannabis Corp. TRLV
11.09 USD +0.08 (+0.73%)
At closeNov 10, 2026, 6:19 PM EST
11.01 -0.08 -0.72%
After hours · Nov 10, 6:19 PM ET
10.71 Day range 11.09
4.62 52-week range 13.28
- YTD
- +27.62%
- 1 year
- +50.68%
News
benzinga.com Trulieve Cannabis Q3 Adj. EPS $0.09 Beats $0.05 Estimate, Sales $230.000M Beat $218.321M Estimate Trulieve Cannabis (NYSE:TRLV) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.05 by 80 percent. The company reported quarterly sales of $230.000 million…
prnewswire.com Trulieve Reports Third Quarter 2026 Results Third quarter revenue of $230 million, with 64% gross margin Cash flow from operations of $183 million and free cash flow of $120 million* in first nine months of 2026 Received final DEA…
benzinga.com Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.- benzinga.com Trulieve Cannabis Awarded Registrations For Medical Marijuana Dispensaries From U.S. Drug Enforcement Administration Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that Trulieve has received registrations for…
benzinga.com Deckers Outdoor Posts Mixed Q2 Results, Joins BayCom, Five Point Holdings And Other Big Stocks Moving Lower In Friday’s Pre-Market Session U.S. stock futures fell, led by Deckers down 9% after mixed results and reduced FY27 guidance. BayCom, ROLR, Trulieve and others also slid premarket.
benzinga.com Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.
benzinga.com Full Transcript: Trulieve Cannabis Q2 2026 Earnings Call On Friday, Trulieve Cannabis (NYSE:TRLV) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For…
benzinga.com Crude Oil Rises Over 1%; Conagra Brands Earnings Top Views U.S. stocks mixed: Dow fell over 200 points, while Nasdaq and S&P 500 rose; inflation cooled and Q2 GDP was revised higher.
benzinga.com Concentrix Posts Mixed Q3 Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session Concentrix plunged 10.6% premarket after weak guidance, despite an earnings beat; several other stocks also traded lower.
benzinga.com Why FingerMotion Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket FingerMotion jumped 18.1% premarket after agreeing to buy Newbit Technology for $2.3M cash; NewGenIvf led gainers at 187.2%, while Silexion fell 16.6%.
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market session. The company's market cap stands at $4.5 million. AIxCrypto Hldgs (NASDAQ:AIXC) stock moved…- benzinga.com Trulieve Cannabis Announces It Has Been Added To S&P Total Market Index And S&P Completion Index Also added to sector sub-indices S&P TMI Health Care and S&P CI Health Care.The S&P TMI is one of the broadest equity benchmarks published by S&P Dow Jones Indices, encompassing a wide range of U.S.
- benzinga.com Trulieve Cannabis Opens New Medical Cannabis Dispensary In Dunwoody, Georgia New DeKalb County location will host grand opening celebration Thursday, September 10TALLAHASSEE, Fla., Sept. 4, 2026 /CNW/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a
benzinga.com Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.
benzinga.com Trulieve Cannabis Q2 Adj. EPS $0.11 Beats $0.06 Estimate, Sales $271.000M Beat $268.494M Estimate Trulieve Cannabis (NYSE:TRLV) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.06 by 83.33 percent. This is a 375 percent increase over losses of $(0.04)…- benzinga.com Cantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15 Cantor Fitzgerald analyst Gabie Ingoglia initiates coverage on Trulieve Cannabis (NYSE:TRLV) with a Overweight rating and announces Price Target of $15.
benzinga.com Trulieve Cannabis CEO To Terminate 10b5-1 Share Sale Plan After Completing First Tranche Of 2.5M Share Disposition Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that Ms. Kim Rivers, the Company's Chairman and Chief
benzinga.com Jim Cramer Calls CAVA 'Tasty, Clean, Fun,' Says Make This Biotech 'Your Speculation' Jim Cramer recommended buying CAVA Group (CAVA), citing its potential and tasty, clean, and fun concept, also likes Trulieve Cannabis (TRLV) and advised holding onto Ashland (ASH).
benzinga.com Trulieve Makes History As First US Cannabis Stock On NYSE https://www.benzinga.com/markets/equities/26/06/53113507/trump-says-iran-took-too-long-and-will-pay-the-price-markets-already-are